Lipoprotein(a) Lowering Medications - Another Step Forward in Atherosclerosis Management.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of cardiovascular pharmacology"
DOI: 10.1097/fjc.0000000000001438
Abstract: CONCLUSION ASO and siRNA agents targeting Lp(a) appear to be promising treatment options for patients with elevated Lp(a) in addition to the classical therapies with statins or other cholesterol lowering drugs. read more here.
Keywords: forward atherosclerosis; another step; step forward; lipoprotein lowering ... See more keywords